AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMOXICILLIN + CLAVULANIC
9 registrations across 2 African markets— 8 active
Markets with AMOXICILLIN + CLAVULANIC
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CLAVOMAX 375 TABLETS (Each tablet contains Amoxicillin 250mg/ Clavulanic acid 125mg) | 🇬🇭Ghana | — | active | Jun 2031 |
| CLAVOMAX 375 TABLETS (Each tablet contains Amoxicillin 250mg/ Clavulanic acid 125mg) | 🇬🇭Ghana | — | active | Jun 2031 |
| CLAVU-NOVA 1G TABLETS | 🇬🇭Ghana | — | expired | Sept 2026 |
| CLAVU-NOVA 1G TABLETS | 🇬🇭Ghana | — | active | Sept 2026 |
| CLAVU-NOVA 1G TABLETS | 🇬🇭Ghana | — | active | Sept 2026 |
| AMOXICILLIN +
CLAVULANIC ORAL LIQUID
ORDINARY DRY
SUSPENSIONS/S
YRUPS/DROPS | 🇺🇬Uganda | DAR AL DAWA DEVELOPMENT AND INVESTMENT CO LTD | active | — |
| AMOXICILLIN +
CLAVULANIC ORAL LIQUID
ORDINARY DRY
SUSPENSIONS/SYRU
PS/DROPS | 🇺🇬Uganda | DAR AL DAWA DEVELOPMENT AND INVESTMENT CO LTD | active | — |
| AMOXICILLIN +
CLAVULANIC ORAL LIQUID
ORDINARY DRY
SUSPENSIONS/SYRU
PS/DROPS | 🇺🇬Uganda | DAR AL DAWA DEVELOPMENT AND INVESTMENT CO LTD | active | — |
| AMOXICILLIN +
CLAVULANIC ORAL LIQUID
ORDINARY DRY
SUSPENSIONS/S
YRUPS/DROPS | 🇺🇬Uganda | DAR AL DAWA DEVELOPMENT AND INVESTMENT CO LTD | active | — |
AMOXICILLIN + CLAVULANIC in Africa — Regulatory Overview
AMOXICILLIN + CLAVULANIC is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.